This is an ongoing prospective cohort study in which we will measure ctDNA specifically from older patients with ER+ breast cancer to monitor treatment response to primary endocrine therapy (the pills you are taking).
This is an ongoing prospective cohort study in which we will measure ctDNA specifically from older patients with ER+ breast cancer to monitor treatment response to primary endocrine therapy (the pills you are taking).